UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

JAMA : the journal of the American Medical Association, 2008-02, Vol.299 (8), p.914

2008

Link zum Volltext

Verfügbarkeit prüfen

Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project

Drug safety, 2015-02, Vol.38 (2), p.183-187

2015

Link zum Volltext

Verfügbarkeit prüfen

Serial Plasma Voriconazole Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.1793-1796

2009

Link zum Volltext

Verfügbarkeit prüfen

Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event

Blood, 2014-05, Vol.123 (18), p.2895-2897

2014

Link zum Volltext

Verfügbarkeit prüfen

Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project

British journal of haematology, 2006-12, Vol.135 (5), p.642-650

2006

Link zum Volltext

Verfügbarkeit prüfen

Accelerated Approval of Cancer Drugs: Improved Access to Therapeutic Breakthroughs or Early Release of Unsafe and Ineffective Drugs?

Journal of clinical oncology, 2009-09, Vol.27 (26), p.4398-4405

2009

Link zum Volltext

Verfügbarkeit prüfen

Changing Epidemiology of Clostridium difficile– Associated Disease during Stem Cell Transplantation

Biology of blood and marrow transplantation, 2013-03, Vol.19 (3), p.405-409

2013

Link zum Volltext

Verfügbarkeit prüfen

Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia

Leukemia research, 2012-04, Vol.36 (4), p.394-396

2012

Link zum Volltext

Verfügbarkeit prüfen

Variability of cyclosporine concentrations by HPLC and TDX monoclonal assay methods, application of a correction factor, and description of a novel clinical approach to determine the practical consequences of changing assay technique

Clinical transplantation, 2013-01, Vol.27 (1), p.154-161

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Hepatotoxicity with Off-Label Oral-Treatment Doses of Voriconazole for Invasive Fungal Infections

Antimicrobial Agents and Chemotherapy, 2011-01, Vol.55 (1), p.184-189

2011

Link zum Volltext

Verfügbarkeit prüfen

The Research on Adverse Drug Events and Reports (RADAR) project

JAMA : the journal of the American Medical Association, 2005-05, Vol.293 (17), p.2131

2005

Link zum Volltext

Verfügbarkeit prüfen

Aztreonam and Vancomycin for Initial Treatment of Febrile Neutropenia in Penicillin-Allergic Patients During Hematopoietic Stem Cell Transplantation

Journal of the advanced practitioner in oncology, 2019-09, Vol.10 (7), p.685-690

2019

Link zum Volltext

Verfügbarkeit prüfen

Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project

Drug safety, 2013-05, Vol.36 (5), p.335-347

2013

Link zum Volltext

Verfügbarkeit prüfen

Cancer‐Associated Neutropenic Fever: Clinical Outcome and Economic Costs of Emergency Department Care

The oncologist (Dayton, Ohio), 2007-08, Vol.12 (8), p.1019-1026

2007

Link zum Volltext

Verfügbarkeit prüfen

Revisiting Infectious Complications Following Total Parenteral Nutrition Use During Hematopoietic Stem Cell Transplantation

Journal of the advanced practitioner in oncology, 2020-09, Vol.11 (7), p.675-682

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs

Expert opinion on drug safety, 2013-05, Vol.12 (3), p.299-307

2013

Link zum Volltext

Verfügbarkeit prüfen

Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review

Annals of hematology, 2016-03, Vol.95 (4), p.563-573

2016

Link zum Volltext

Verfügbarkeit prüfen

Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem‐cell transplantation

Clinical transplantation, 2018-01, Vol.32 (1), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Tacrolimus dose modification in patients receiving concomitant isavuconazole after hematopoietic stem cell transplantation

Journal of oncology pharmacy practice, 2021-06, Vol.27 (4), p.857-862

2021

Link zum Volltext

Verfügbarkeit prüfen

Managing Tumor Lysis Syndrome in the Era of Novel Cancer Therapies

Journal of the advanced practitioner in oncology, 2017-11, Vol.8 (7), p.705-720

2017

Link zum Volltext

Verfügbarkeit prüfen

Update on Antifungal Drug Dosing and Therapeutic Drug Monitoring

Current fungal infection reports, 2011-06, Vol.5 (2), p.92-102

Trifilio, Steven

2011

Link zum Volltext

Verfügbarkeit prüfen

Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis

Bone marrow transplantation (Basingstoke), 2016-02, Vol.51 (2), p.277-282

2016

Link zum Volltext

Verfügbarkeit prüfen

Economics of Malignant Gliomas: A Critical Review

Journal of oncology practice, 2015-01, Vol.11 (1), p.e59

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Humans
(33)
Female
(22)
Male
(22)
Middle Aged
(18)
Adult
(16)
Aged
(15)
Hematology
(15)
Hematology, Oncology And Palliative Medicine
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Oncology
(12)
Retrospective Studies
(8)
Pharmacology & Pharmacy
(7)
Risk Factors
(7)
Adolescent
(6)
Hematopoietic Stem Cell Transplantation
(6)
Immunology
(6)
Transplantation
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project

Serial Plasma Voriconazole Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation

Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event

Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death

Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project

Accelerated Approval of Cancer Drugs: Improved Access to Therapeutic Breakthroughs or Early Release of Unsafe and Ineffective Drugs?

Changing Epidemiology of Clostridium difficile– Associated Disease during Stem Cell Transplantation

Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia

Variability of cyclosporine concentrations by HPLC and TDX monoclonal assay methods, application of a correction factor, and description of a novel clinical approach to determine the practical consequences of changing assay technique

Evaluation of Hepatotoxicity with Off-Label Oral-Treatment Doses of Voriconazole for Invasive Fungal Infections

The Research on Adverse Drug Events and Reports (RADAR) project

Aztreonam and Vancomycin for Initial Treatment of Febrile Neutropenia in Penicillin-Allergic Patients During Hematopoietic Stem Cell Transplantation

Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project

Cancer‐Associated Neutropenic Fever: Clinical Outcome and Economic Costs of Emergency Department Care

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project

Revisiting Infectious Complications Following Total Parenteral Nutrition Use During Hematopoietic Stem Cell Transplantation

Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs

Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review

Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem‐cell transplantation

Tacrolimus dose modification in patients receiving concomitant isavuconazole after hematopoietic stem cell transplantation

Managing Tumor Lysis Syndrome in the Era of Novel Cancer Therapies

Update on Antifungal Drug Dosing and Therapeutic Drug Monitoring

Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis

Economics of Malignant Gliomas: A Critical Review

Suchergebnisse filtern